Symphony product shot
Symphony Thrombectomy System Logo

More Clot. Less Time. Full Control.

Symphony

Symphony, the first large-bore continuous vacuum system for venous thromboembolism (VTE), gives physicians improved control over their procedures, allowing them to remove more clot in less time and to provide better care for their patients.

Download the product specs

Important safety information

Legacy thrombectomy 
comes with compromise…

Until now, physicians treating VTE have had to choose between large-bore power and ease of use.

Large-Bore Confidence with Precise Deep Vacuum Control

Large-Bore Confidence with Precise Deep Vacuum Control

Symphony was engineered to overcome these tradeoffs by combining large-bore power with precise deep vacuum control, efficiently reducing clot burden with improved speed and precision.

Directional control rotational collar
In-line pressure monitoring & fluid injection
On-demand vacuum rapid recharge
Delivering deep vacuum closer to the clot
Anti-clogging ProHelix mechanical assist
16F/24F sizes to telescope and reach distal anatomy

Full Spectrum Results

Real-World Venous Experience*

Real-World Venous Experience*

2

Median passes per case

15min

Median device time

95%

Median clot removed

200ml

Median EBL

* n=171. Data on file.

Read our Endovascular Today article
Collection of blood clot images
Collection of blood clot images

SYMPHONY-PE TRIAL

Trial Objective:

To evaluate the safety and efficacy of the Symphony Thrombectomy System
in the treatment of patients with acute intermediate-risk pulmonary embolism.

Safely and confidently
focus on the patient.

0.9%

Major adverse event (MAE) through 48 hours

0.0% device-related serious adverse events (SAE)

0%

All-cause mortality rate

Measured through 30 days

250mL

Median aspirated blood

Minimal aspirated blood and no periprocedural blood transfusions

Large-bore power with precise deep vacuum
significantly reduces clot burden.

38.4%

Clot burden reduction based on Refined Modified Miller Index

Largest reduction compared to IDE trials*

7mmHG

Reduction in mean pulmonary artery pressure (PAP)

Largest reduction compared to IDE trials*

0.44RV/LV

Mean reduction in right ventricle–to–left ventricle ratio

Exceeded the prespecified performance goal of > 0.20

Improved versatility, speed and control.

31min

Median device-use time

Fastest reported median time*

16F/24F continuous deep vacuum

Rapid clot evacuation without increased blood loss

Icon of two arrows in a circle

Streamlined procedure

Intraprocedural pulmonary artery pressure (PAP) assessment and contrast imaging

*A Prospective Multicenter IDE Study of the Next-Generation Precision Aspiration Thrombectomy System for Intermediate-Risk Pulmonary Embolism: The SYMPHONY-PE Trial

SEE SYMPHONY IN ACTION

Want to try Symphony for yourself? Let’s make it happen.

Request Demo